author,     year, trial,            comparison,      refract,                outcome, e1,   n1,   e2,   n2,   n,     hr,    hr_lb, hr_ub, pval,   source, notes
Attal,      2019, ICARIA-MM,        IsPd vs Pd,      Refractory to R,        PFS,     72,   144,  82,   140,  .,     0.59,  0.43,  0.82,  .,      Fig. 3, .
Attal,      2019, ICARIA-MM,        IsPd vs Pd,      Not refractory to R,    PFS,     1,    10,   7,    13,   .,     0.18,  0.02,  1.49,  .,      Fig. 3, .
Bahlis,     2020, POLLUX,           DRd vs Rd,       Previous R use,         PFS,     25,   50,   38,   50,   .,     0.38,  0.21,  0.66,  .,      Fig. 2, .
Bahlis,     2020, POLLUX,           DRd vs Rd,       No previous R use,      PFS,     112,  236,  164,  233,  .,     0.45,  0.35,  0.58,  .,      Fig. 2, .
Dimopoulos, 2013, VANTAGE 088,      VorV vs V,       Previous IMiD use,      PFS,     .,    192,  .,    208,  .,     0.757, 0.595, 0.963, 0.0230, Tab. 2, .
Dimopoulos, 2013, VANTAGE 088,      VorV vs V,       No IMiD use,            PFS,     .,    125,  .,    112,  .,     0.926, 0.670, 1.279, 0.6408, Tab. 2, .
Dimopoulos, 2016, ENDEAVOR,         Kd vs Vd,        Not refractory to R,    PFS,     105,  351,  167,  343,  .,     0.44,  0.34,  0.56,  .,      Fig. 3, .
Dimopoulos, 2016, ENDEAVOR,         Kd vs Vd,        Refractory to R,        PFS,     66,   113,  76,   122,  .,     0.80,  0.57,  1.11,  .,      Fig. 3, .
Dimopoulos, 2018, ELOQUENT-3,       EPd vs Pd,       Ref. to R and a PI,     PFS,     23,   41,   30,   41,   .,     0.56,  0.33,  0.97,  .,      Fig. 1, .
Dimopoulos, 2018, ELOQUENT-3,       EPd vs Pd,       Not ref. to R and a PI, PFS,     9,    19,   13,   16,   .,     0.51,  0.21,  1.19,  .,      Fig. 1, .
Dimopoulos, 2021, APOLLO,           DPd vs Pd,       Refractory to R,        PFS,     76,   120,  89,   122,  .,     0.66,  0.49,  0.90,  .,      p. 808, .
Dimopoulos, 2021, APOLLO,           DPd vs Pd,       Not refractory to R,    PFS,     8,    31,   17,   31,   .,     0.36,  0.15,  0.83,  .,      p. 808, .
Hou,        2017, China Cont.,      IRd vs Rd,       Previous IMiD use,      PFS,     28,   52,   31,   47,   .,     0.553, 0.328, 0.931, .,      Fig. 2, .
Hou,        2017, China Cont.,      IRd vs Rd,       No IMiD use,            PFS,     2,    5,    6,    11,   .,     0.766, 0.148, 3.964, .,      Fig. 2, .
Hou,        2017, China Cont.,      IRd vs Rd,       Previous IMiD use,      OS,      19,   52,   29,   47,   .,     0.398, 0.220, 0.719, .,      Fig. 3, .
Hou,        2017, China Cont.,      IRd vs Rd,       No IMiD use,            OS,      2,    5,    7,    11,   .,     0.498, 0.103, 2.403, .,      Fig. 3, .
Jakubowiak, 2016, NCT01478048,      EVd vs Vd,       Previous IMiD use,      PFS,     .,    55,   .,    58,   .,     0.87,  0.58,  1.29,  .,      Fig. 2, .
Jakubowiak, 2016, NCT01478048,      EVd vs Vd,       No IMiD use,            PFS,     .,    22,   .,    17,   .,     0.39,  0.19,  0.80,  .,      Fig. 2, .
Kumar,      2020, BELLINI,          VeVd vs Vd,      Naive,                  PFS,     .,    .,    .,    .,    93,    0.61,  0.31,  1.17,  .,      Fig. S3,.
Kumar,      2020, BELLINI,          VeVd vs Vd,      Refractory to IMiD,     PFS,     .,    .,    .,    .,    100,   0.75,  0.41,  1.36,  .,      Fig. S3,.
Kumar,      2020, BELLINI,          VeVd vs Vd,      Naive,                  OS,      .,    .,    .,    .,    93,    5.90,  0.76,  46.1,  .,      Fig. S4,.
Kumar,      2020, BELLINI,          VeVd vs Vd,      Refractory to IMiD,     OS,      .,    .,    .,    .,    100,   1.82,  0.65,  5.14,  .,      Fig. S4,.
Lonial,     2015, ELOQUENT-2,       ELd vs Ld,       Previous R use,         PFS,     9,    16,   13,   21,   .,     0.59,  0.25,  1.40,  .,      Fig. 1, .
Lonial,     2015, ELOQUENT-2,       ELd vs Ld,       No previous R use,      PFS,     170,  305,  192,  304,  .,     0.70,  0.57,  0.87,  .,      Fig. 1, .
Lu,         2021, LEPUS,            DVd vs Vd,       Refractory to IMiD,     PFS,     24,   93,   22,   41,   .,     0.39,  0.22,  0.69,  .,      Fig. 2, .
Lu,         2021, LEPUS,            DVd vs Vd,       Not refractory to IMiD, PFS,     10,   37,   14,   23,   .,     0.16,  0.07,  0.40,  .,      Fig. 2, .
Mateos,     2020, CASTOR,           DVd vs Vd,       Refractory to IMiD,     PFS,     67,   83,   86,   97,   .,     0.46,  0.31,  0.66,  .,      Fig. 2, .
Mateos,     2020, CASTOR,           DVd vs Vd,       Not refractory to IMiD, PFS,     65,   96,   79,   101,  .,     0.30,  0.20,  0.45,  .,      Fig. 2, .
Moreau,     2021, IKEMA,            IsKd vs Kd,      Refractory to R,        PFS,     23,   57,   25,   42,   .,     0.60,  0.34,  1.06,  .,      Fig. 3, .
Moreau,     2021, IKEMA,            IsKd vs Kd,      Not refractory to R,    PFS,     25,   122,  30,   81,   .,     0.48,  0.28,  0.82,  .,      Fig. 3, .
Orlowski,   2007, NCT00103506,      V vs DoxV,       Previous R or T use,    PFS,     .,    .,    .,    .,    268,   1.62,  1.08,  2.41,  .,      Fig. 3, .
Orlowski,   2007, NCT00103506,      V vs DoxV,       No previous R or T use, PFS,     .,    .,    .,    .,    378,   2.01,  1.42,  2.84,  .,      Fig. 3, .
Orlowski,   2016, NCT00103506,      V vs DoxV,       Previous R or T use,    OS,      .,    .,    .,    .,    278,   0.960, 0.734, 1.256, .       Fig. 3, .
Orlowski,   2016, NCT00103506,      V vs DoxV,       No previous R or T use, OS,      .,    .,    .,    .,    378,   1.080, 0.856, 1.361, .       Fig. 3, .
Orlowski,   2019, ENDEAVOR,         Kd vs Vd,        Previous R use,         OS,      99,   177,  104,  178,  .,     0.877, 0.665, 1.156, .,      Fig. 3, .
Orlowski,   2019, ENDEAVOR,         Kd vs Vd,        No previous R use,      OS,      115,  287,  144,  287,  .,     0.684, 0.535, 0.875, .,      Fig. 3, .
Orlowski,   2019, ENDEAVOR,         Kd vs Vd,        Refractory to R,        OS,      70,   113,  84,   123,  .,     0.857, 0.623, 1.178, .,      Fig. 3, .
Palumbo,    2016, CASTOR,           DVd vs Vd,       Refractory to IMiD,     PFS,     34,   83,   58,   97,   .,     0.50,  0.31,  0.80,  .,      Fig. 2, .
Palumbo,    2016, CASTOR,           DVd vs Vd,       Not refractory to IMiD, PFS,     17,   96,   43,   101,  .,     0.32,  0.18,  0.59,  .,      Fig. 2, .
Richardson, 2019, OPTIMISMM,        PVd vs Vd,       Refractory to R,        PFS,     120,  200,  118,  191,  .,     0.65,  0.50,  0.84,  .,      Fig. 3, .
Richardson, 2019, OPTIMISMM,        PVd vs Vd,       Not refractory to R,    PFS,     34,   81,   44,   87,   .,     0.48,  0.30,  0.75,  .,      Fig. 3, .
Richardson, 2021, TOURMALINE-MM1,   IRd vs Rd,       Refractory to T,        OS,      26,   39,   36,   50,   .,     0.781, 0.461, 1.322, .,      Fig. 2, .
Richardson, 2021, TOURMALINE-MM1,   IRd vs Rd,       Not refractory to T,    OS,      214,  321,  208,  312,  .,     0.975, 0.804, 1.183, .,      Fig. 2, .
San-Miguel, 2016, PANORAMA 1,       FVd vs Vd,       Previous IMiD use,      OS,      .,    .,    .,    .,    485,   0.94,  0.74,  1.19,  .,      Fig. 3, .
San-Miguel, 2016, PANORAMA 1,       FVd vs Vd,       No previous IMiD use,   OS,      .,    .,    .,    .,    283,   0.93,  0.66,  1.31,  .,      Fig. 3, .
Stewart,    2015, ASPIRE,           KRd vs Rd,       Refractory to IMiD,     PFS,     .,    85,   .,    88,   .,     0.64,  0.44,  0.91,  .,      Fig. 1, .
Stewart,    2015, ASPIRE,           KRd vs Rd,       Not refractory to IMiD, PFS,     .,    311,  .,    308,  .,     0.72,  0.58,  0.90,  .,      Fig. 1, .
Usmani,     2022, CANDOR,           DKd vs Kd,       Refractory to R,        PFS,     46,   99,   35,   55,   .,     0.46,  0.28,  0.73,  .,      Fig. 3, .
Usmani,     2022, CANDOR,           DKd vs Kd,       Not refractory to R,    PFS,     94,   213,  50,   99,   .,     0.63,  0.44,  0.90,  .,      Fig. 3, .
